AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Syncom Formulations Files SEBI Compliance Certificate for Q3 FY26

Syncom Formulations (India) Limited

AI Sentiment Analysis

January 8, 2026, 09:49 AM

Top Queries to Ask About Syncom Formulations (India) Limited

Thinking to buy or sell Syncom Formulations (India) Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Syncom Formulations (India) Limited has submitted a certificate in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025.

The certificate, received from their Registrar and Share Transfer Agent, M/s Ankit Consultancy Pvt. Ltd., confirms compliance with the SEBI regulations. It states that securities received from depository participants for dematerialization during the quarter were confirmed (accepted/rejected) to the depositories. Furthermore, the security certificates received for dematerialization were duly mutilated and cancelled after verification, with the depositories' names substituted in the register of members as the registered owner within 15 days.

The company has submitted this document to BSE Limited and the National Stock Exchange of India Limited for their records and necessary actions.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Syncom Formulations (India) Limited

Analyze Syncom Formulations (India) Limited

Discover more trending news on Prysm

View All